NasdaqCM - Nasdaq Real Time Price USD

Sharps Technology, Inc. (STSS)

4.7300

-0.3200

(-6.34%)

At close: May 9 at 4:00:01 PM EDT

4.8900

+0.16

+(3.38%)

After hours: May 9 at 7:58:19 PM EDT

Sharps Technology Receives ~$100K Initial Purchase Order from Hungarian Vaccine Provider for SecureGard™ Syringes

Sharps also received an initial qualification purchase order for DisGard™ single-use Sharps Recovery System Company transitions to revenue producing with second purchase order, bringing total recent orders to approximately $500,000 for the quarter NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart-safety syringe products to the healthca

GlobeNewswire 5 days ago

STSS
-6.34%

STSSW
Sharps Technology Secures $400K Initial Purchase Order from U.S. Leader in IV Flushing Solutions as Part of $50 Million SoloGard Supply Agreement

Milestone order marks first commercial revenue for Sharps Technology under multi-year, 500-million syringe agreementInvestments in best-in-class manufacturing equipment position Sharps to offer differentiated high-volume syringe production to meet long-term contract demand NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart-safety syri

GlobeNewswire 11 days ago

STSS
-6.34%

STSSW
Sharps Technology to effect 1-for-300 reverse stock split

Sharps Technology (STSS) will effect a 1-for-300 reverse stock split of its common stock, par value $0.0001 per share, that will become effective on April 27, 2025 at 11:59 PM Eastern Time, before the opening of trading on The Nasdaq Capital Market. Sharps has requested that its Common Stock begin trading on April 28, 2025, on a post-reverse split basis on the Nasdaq under the existing symbol “STSS”. The reverse split is primarily intended to bring Sharps into compliance with the minimum bid pri

TipRanks 16 days ago

STSS
-6.34%

STSSW
Sharps Technology Announces Reverse Stock Split

NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: “STSS” and “STSSW”) ("Sharps"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart-safety syringe products to the healthcare industry, today announced that it will effect a 1-for-300 reverse stock split (the "reverse split") of its common stock, par value $0.0001 per share (the "Common Stock"), that will become effective on April 27, 2025 at 11:59 PM Eastern Time, b

GlobeNewswire 17 days ago

STSS
-6.34%

STSSW
Sharps Technology, Inc. Reminds Shareholders to Vote Before Important Shareholder Meeting on March 28, 2025

Voting 'FOR' the Proposed Stock Split is Crucial to Keep STSS Listed on Nasdaq and Prevent Delisting to the OTC MarketsNEW YORK, March 20, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (Nasdaq: STSS) (the “Company” or “Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, is reminding shareholders to vote their proxy in favor of the Company’s proposal before the shareholder meeting, which is scheduled to be held on March

GlobeNewswire last month

STSS
-6.34%

STSSW
Sharps Technology, Inc. (STSS): Among the Most Active US Stocks to Buy According to Hedge Funds

We recently published a list of 10 Most Active US Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Sharps Technology, Inc. (NASDAQ:STSS) stands against other most active US stocks to buy according to hedge funds. Over the past five years, the U.S. stock market […]

Insider Monkey last month

STSSW
Sharps Technology’s CEO Issues Corporate Update Highlighting Agreements for SecureGard and SoloGard and Revenue Developments from Manufacturing Operations in Hungary

Company is strategically positioned following the recent $20 million capital raise, enhancing manufacturing capabilities to accelerate qualification and shipments under existing agreementsNEW YORK, March 06, 2025 (GLOBE NEWSWIRE) -- Dear Fellow Shareholders, As we reflect on the progress since our December update, I am excited to share the latest developments that will shape our Company’s trajectory in 2025 and beyond. With the successful closing of a $20 million financing in January, we strengt

GlobeNewswire 2 months ago

STSS
-6.34%

STSSW
Sharps Technology, Inc. Announces Closing of Upsized $20.0 Million Underwritten Public Offering

NEW YORK, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: STSS) (the “Company”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, today announced the closing of its previously announced firm commitment underwritten public offering. Gross proceeds to the Company were approximately $20.0 million, before deducting underwriting fees and other offering expenses payable by the Company. The offering closed on January

GlobeNewswire 3 months ago

STSS
-6.34%

STSSW
Sharps Technology, Inc. Announces Pricing of Upsized $20.0 Million Underwritten Public Offering

NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: STSS) (the “Company”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, today announced the pricing of a firm commitment underwritten public offering with gross proceeds to the Company expected to be approximately $20.0 million, before deducting underwriting fees and other estimated offering expenses payable by the Company. The offering consists of 14,2

GlobeNewswire 3 months ago

STSS
-6.34%

STSSW
Sharps Technology’s CEO Issues Shareholder Letter Highlighting Hungary Manufacturing Facility Expansion Plans to Increase SecureGard and SoloGard Product Supply and Revenue

Shareholder letter includes details about the $50+ million sales agreement with a US-based pharma company, plans for Hungary SoloGard manufacturing expansion, and expected delivery scheduleInitial production and commercial deliveries to begin in Q1 2025 Sales team has signed an agreement to sell and deliver current SecureGard 1mL and 3mL inventory, with shipments and revenue that began in early December NEW YORK, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc., (NASDAQ: “STSS” and “STS

GlobeNewswire 5 months ago

STSS
-6.34%

STSSW
Sharps Technology Signs Sales Agreements to Support Major European Healthcare Network and Sells Out Its Inventory for SecureGard

Signed multiple agreements to sell its SecureGard syringe inventory, with initial shipments and revenue commencing in early DecemberAgreements also include new forecasted orders and commitments for all current SecureGard capacity, to begin in Q2 2025The SecureGard agreements will strengthen the potential revenue curve for the Hungary Operation starting in 2024 NEW YORK, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharma

GlobeNewswire 5 months ago

STSS
-6.34%

STSSW
Sharps Regains Nasdaq Listing Compliance

NEW YORK, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, today announced that on November 13, 2024, the Company was notified by the Nasdaq Stock Market (“Nasdaq”) that the Company had regained compliance with the minimum bid price requirement of $1.00 per share for continued listing on the Nasdaq Stock Market, as set forth in Nas

GlobeNewswire 5 months ago

STSS
-6.34%

STSSW
Sharps Technology, Inc. Announces Stockholders’ Approval of Reverse Stock Split Ratio and Effective Date

NEW YORK, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: “STSS” and “STSSW”) ("Sharps"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, today announced that it will effect a one-for-22 reverse stock split (the "reverse split") of its common stock, par value $0.0001 per share (the "Common Stock"), that will become effective on October 15, 2024 at 11:59 PM Eastern Time, before the opening of trading on The Na

GlobeNewswire 6 months ago

STSS
-6.34%

STSSW
Empery Asset Management's Strategic Reduction in Sharps Technology Inc

On September 30, 2024, Empery Asset Management, LP (Trades, Portfolio) executed a significant transaction involving the sale of 452,869 shares of Sharps Technology Inc (NASDAQ:STSS), a noted player in the medical devices sector. This move adjusted their holding to a total of 783,613 shares, marking a notable shift in their investment strategy regarding this stock. Located at 1 Rockefeller Plaza, New York, Empery Asset Management, LP (Trades, Portfolio) is known for its sharp investment strategies and a keen focus on maximizing returns.

GuruFocus.com 6 months ago

STSSW
Sharps Technology, Inc. Reminds Shareholders to Vote Before Important Shareholder Meeting on October 7, 2024

NEW YORK, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: STSS) (the “Company”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, is reminding shareholders to vote their proxy in favor of the Company’s proposal before the shareholder meeting scheduled to be held on October 7, 2024 at 10:00 a.m. Eastern Time. “Please take a very important step to preserve your investment and to help ensure that Sharps Technolo

GlobeNewswire 7 months ago

STSS
-6.34%

STSSW
Aegis Capital Corp. Acted as Exclusive Placement Agent on a $3.5 Million Bridge Financing for Sharps Technology, Inc. (NASDAQ:STSS)

NEW YORK, NY / ACCESSWIRE / September 27, 2024 / Aegis Capital Corp. acted as Exclusive Placement Agent on a $3.5 Million Bridge Financing for Sharps Technology, Inc. (NASDAQ:STSS). About Sharps Technology, Inc. Sharps Technology, Inc., a medical ...

ACCESS Newswire 7 months ago

STSS
-6.34%

STSSW
Sharps Technology, Inc. Closes $3.5 Million Bridge Financing

NEW YORK, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: STSS) (the “Company”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, today announced the closing of its previously announced secured bridge loan financing (the “Bridge Financing”) of approximately $3.5 million. The Bridge Financing consisted of the sale of approximately $3.5 million in securities, with purchasers agreeing to buy, for each $1,000 inv

GlobeNewswire 7 months ago

STSS
-6.34%

STSSW
Sharps Technology, Inc. Announces $3.5 Million Bridge Financing

NEW YORK, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: STSS) (the “Company”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, today announced that it has entered into definitive agreements with institutional investors for a secured bridge loan financing (the “Bridge Financing”) of approximately $3.5 million. The Bridge Financing consisted of the sale of approximately $3.5 million in securities, with purch

GlobeNewswire 7 months ago

STSS
-6.34%

STSSW
Sharps Technology Announces Continued Listing on Nasdaq Pending Results of an Upcoming Special Shareholders’ Meeting

NEW YORK, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc., (NASDAQ: STSS and STSSW) (“Sharps Technology” or the “Company”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, announced today that the Company has secured approval from The Nasdaq Stock Market (“Nasdaq” or the “Exchange”) to maintain its listing, subject to conditions outlined below. On September 9, 2024, Sharps Technology received a Determination Letter f

GlobeNewswire 7 months ago

STSS
-6.34%

STSSW
Sharps Technology Enters Into a Five-Year Sales Agreement with Strategic U.S. Medical Products Company Creating +$5O Million in New Revenue for EU Facility

Definitive agreement sells out the 10mL SoloGard production capacity at Sharps’ manufacturing site in the EU and drives expansion to support the project’s growth in the future Sharps’ portfolio of products provides attractive options to the U.S. Pharmaceutical Healthcare Industry as companies look for alternatives to Chinese-manufactured disposable syringes Sharps has exceeded the product sales commitments for the EU-based facility made to investors in the June 2022 Shareholder Letter NEW YORK,

GlobeNewswire 9 months ago

STSS
-6.34%

STSSW

Performance Overview

Return	STSS	S&P 500 (^GSPC)
YTD	-99.23%	-3.77%
1-Year	-99.69%	+8.55%
3-Year	-99.94%	+41.81%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Sharps Technology, Inc. (STSS)

Sharps Technology Receives ~$100K Initial Purchase Order from Hungarian Vaccine Provider for SecureGard™ Syringes

Sharps Technology Secures $400K Initial Purchase Order from U.S. Leader in IV Flushing Solutions as Part of $50 Million SoloGard Supply Agreement

Sharps Technology to effect 1-for-300 reverse stock split

Sharps Technology Announces Reverse Stock Split

Sharps Technology, Inc. Reminds Shareholders to Vote Before Important Shareholder Meeting on March 28, 2025

Sharps Technology, Inc. (STSS): Among the Most Active US Stocks to Buy According to Hedge Funds

Sharps Technology’s CEO Issues Corporate Update Highlighting Agreements for SecureGard and SoloGard and Revenue Developments from Manufacturing Operations in Hungary

Sharps Technology, Inc. Announces Closing of Upsized $20.0 Million Underwritten Public Offering

Sharps Technology, Inc. Announces Pricing of Upsized $20.0 Million Underwritten Public Offering

Sharps Technology’s CEO Issues Shareholder Letter Highlighting Hungary Manufacturing Facility Expansion Plans to Increase SecureGard and SoloGard Product Supply and Revenue

Sharps Technology Signs Sales Agreements to Support Major European Healthcare Network and Sells Out Its Inventory for SecureGard

Sharps Regains Nasdaq Listing Compliance

Sharps Technology, Inc. Announces Stockholders’ Approval of Reverse Stock Split Ratio and Effective Date

Empery Asset Management's Strategic Reduction in Sharps Technology Inc

Sharps Technology, Inc. Reminds Shareholders to Vote Before Important Shareholder Meeting on October 7, 2024

Aegis Capital Corp. Acted as Exclusive Placement Agent on a $3.5 Million Bridge Financing for Sharps Technology, Inc. (NASDAQ:STSS)

Sharps Technology, Inc. Closes $3.5 Million Bridge Financing

Sharps Technology, Inc. Announces $3.5 Million Bridge Financing

Sharps Technology Announces Continued Listing on Nasdaq Pending Results of an Upcoming Special Shareholders’ Meeting

Sharps Technology Enters Into a Five-Year Sales Agreement with Strategic U.S. Medical Products Company Creating +$5O Million in New Revenue for EU Facility

Performance Overview